Tel:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@anticorps-enligne.fr

Acetylated Lysine anticorps

L’anticorps anti-Acetylated Lysine Monoclonal Souris est utilisé pour la détection de Acetylated Lysine. Il a été validé pour WB, ELISA et IHC.
Rockland
N° du produit ABIN6655030
N° du produit (Fournisseur): 200-301-a97
628,53 €
Frais d'envoi 40,00 €, glace carbonique 20,00 € et TVA exclus
100 μg
Destination: France
Envoi sous 5 à 8 jours ouvrables

Aperçu rapide pour Acetylated Lysine anticorps (ABIN6655030)

Antigène

Acetylated Lysine

Reactivité

Veuillez nous consulter SVP

Hôte

  • 28
  • 19
Souris

Clonalité

  • 26
  • 20
Monoclonal

Conjugué

  • 19
  • 5
  • 5
  • 3
  • 3
  • 2
  • 2
  • 2
  • 2
  • 2
  • 1
  • 1
Cet anticorp Acetylated Lysine est non-conjugé

Application

  • 44
  • 34
  • 33
  • 18
  • 15
  • 14
  • 4
  • 4
  • 3
  • 3
  • 2
  • 2
  • 2
  • 1
  • 1
  • 1
Western Blotting (WB), ELISA, Immunohistochemistry (IHC)

Clone

7F8
  • N° du produit (Fournisseur)

    200-301-a97

    Fournisseur

    Rockland

    Fonction

    Lysine Acetylated Antibody

    Réactivité croisée (Details)

    This antibody is known to react with acetylated lysine residues from mammalian and avian sources.

    Purification

    This Protein G purified monoclonal antibody reacts with proteins containing acetylated lysine residues and does not detect non-acetylated lysine residues.

    Stérilité

    Sterile filtered

    Immunogène

    This Protein G purified monoclonal antibody was prepared using conventional hybridoma technology after repeated immunizations with acetylated keyhole limpet hemocyanin (KLH).

    Isotype

    IgG1
  • Indications d'application

    ELISA_Dilution: User Optimized

    Immunohistochemistry_Dilution: 1:200 - 1:1,000

    Western_Blot_Dilution: 1:500 - 1:2,000

    Other: User Optimized

    Commentaires

    This Protein G purified antibody has been tested for use in ELISA, immunohistochemistry and western blotting.  Specific conditions for reactivity should be optimized by the end user.  Approximately 1 μg of antibody is sufficient to detect 20 μg of acetylated chicken erythrocyte histones (sodium butyrate treated) by Western blotting using HRP Gt-a-Mouse IgG (p/n 610-103-121) and chemiluminescent substrate (p/n PICOMAX-110). Antibody provided in PBS pH 7.4.

    Restrictions

    For Research Use only
  • Format

    Liquid

    Buffer

    Buffer: See application note.

    Stabilizer: 50 % (v/v) Glycerol

    Preservative: 0.09 % (w/v) Sodium Azide

    Agent conservateur

    Sodium azide

    Précaution d'utilisation

    This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

    Stock

    4 °C,-20 °C

    Stockage commentaire

    Store vial at -20° C prior to opening. Aliquot contents and freeze at -20° C or below for extended storage. Avoid cycles of freezing and thawing. Centrifuge product if not completely clear after standing at room temperature. This product is stable for several weeks at 4° C as an undiluted liquid. Dilute only prior to immediate use.

    Date de péremption

    12 months
  • Antigène

    Acetylated Lysine

    Autre désignation

    Lysine Acetylated

    Classe de substances

    Chemical

    Sujet

    Synonyms: acetyl Lysine antibody, Acetylated lysine antibody, Lysine antibody

    Background: Post-translational modifications of proteins play critical roles in the regulation and function of many known biological processes. A common posttranscriptional modification of lysine residues involves acetylation (1). The conserved amino-terminal domains of the four core histones (H2A, H2B, H3 and H4) contain lysines that are acetylated by histone acetyltransferases (HATs) and deacetylated by histone deacetylases (HDACs) (2). Protein posttranslational reversible lysine Nε-acetylation and deacetylation have been recognized as an emerging intracellular signaling mechanism that plays critical roles in regulating gene transcription, cell-cycle progression, apoptosis, DNA repair, and cytoskeletal organization (3). The regulation of protein acetylation status is impaired in the pathologies of cancer and polyglutamine diseases (4). HDACs therefore are promising targets for anticancer drugs currently in development (5).

Vous êtes ici:
Chat with us!